The pharmaceutical industry has historically taken a cautious approach to new advancements. But now, it is embracing the possibilities of continuous manufacturing technologies. While traditional batch based processes are still the industry standard, there are several products on the market that have utilized continuous manufacturing practices in their development. Over the last decade, this approach has generated a considerable amount of attention. To take a deeper look at the issues surrounding continuous processing, American Pharmaceutical Review has spoken with some of the industry’s thought leaders on the subject. We spoke with experts from regulatory, manufacturing, consulting, market research, and technology providers. Here is their unique take on the topic.